Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
NCT05180591Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2022
- Primary completion
- Mar 2031
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started Mar 2022; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05180591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05180591.